Jung-Won Park

Jung-Won Park

Auto-generated profile, based on publicly available information

Jung-Won Park

Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CTChristian Taube
Christian Taube
CDCatherine Duez
Catherine Duez
ZCZhi-Hua Cui
Zhi-Hua Cui
KTKatsuyuki Takeda
Katsuyuki Takeda
YRYeong-Ho Rha
Yeong-Ho Rha
EGErwin W. Gelfand
Erwin W. Gelfand
The effectiveness of targeting IL-13 in models where airway hyperresponsiveness (AHR) and airway inflammation have already been established is not well-described. We investigated the effects of blocking IL-13 on the early and late phase airway responses and the development of AHR in previously sensitized and challenged mice. BALB/cByJ mice were sensitized (days 1 and 14) and challenged (days 28–30) with OVA. Six weeks later (day 72), previously sensitized/challenged mice were challenged with a single OVA aerosol and the early and late phase response and development of AHR were determined. Specific in vivo blockade of IL-13 was attained after i.p. injection of a soluble IL-13Rα2-IgG fusion protein (sIL-13Rα2Fc) on days 71–72 for the early and late responses and on days 71–73 for the development of AHR. sIL-13Rα2Fc administration inhibited the late, but not early, phase response and the OVA challenge-induced changes in lung resistance and dynamic compliance; as well, sIL-13Rα2Fc administration decreased bronchoalveolar lavage eosinophilia and mucus hypersecretion following the secondary challenge protocols. These results demonstrate that targeting IL-13 alone regulates airway responses when administrated to mice with established allergic airway disease. These data identify the importance of IL-13 in the development of allergen-induced altered airway responsiveness following airway challenge, even when administered before rechallenge of mice in which allergic disease had been previously established.

9 April 2006 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JCJe-Min Choi
Je-Min Choi
MAMi-Hyun Ahn
Mi-Hyun Ahn
WCWook-Jin Chae
Wook-Jin Chae
YJYung-Gook Jung
Yung-Gook Jung
JPJae-Chul Park
Jae-Chul Park
SLSang-Kyou Lee
Sang-Kyou Lee

1 August 2005 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ADAzzeddine Dakhama
Azzeddine Dakhama
JPJung-Won Park
Jung-Won Park
CTChristian Taube
Christian Taube
AJAnthony Joetham
Anthony Joetham
ABAnnette Balhorn
Annette Balhorn
EGErwin W. Gelfand
Erwin W. Gelfand
Respiratory syncytial virus (RSV) infection in early life is suspected to play a role in the development of postbronchiolitis wheezing and asthma. Reinfection is common at all ages, but factors that determine the development of altered airway function after reinfection are not well understood. This study was conducted in a mouse model to define the role of age in determining the consequences on airway function after reinfection. Mice were infected shortly after birth or at weaning and were reinfected 5 wk later, followed by assessment of airway function, airway inflammation, and lung histopathology. Infection of mice at weaning elicited a protective airway response upon reinfection. In this age group, reinfection resulted in increased airway inflammation, but without development of airway hyperresponsiveness (AHR) or eosinophilia and decreased IL-13 levels. By contrast, neonatal infection failed to protect the airways and resulted in enhanced AHR after reinfection. This secondary response was associated with the development of airway eosinophilia, increased IL-13 levels, and mucus hyperproduction. Both CD4- and CD8-positive T cells were a source of IL-13 in the lung, and inhibition of IL-13 abolished AHR and mucus production in these mice. Inoculation of UV-inactivated virus failed to elicit these divergent responses to reinfection, emphasizing the requirement for active lung infection during initial exposure. Thus, neonatal RSV infection predisposes to the development of airway eosinophilia and enhanced AHR via an IL-13-dependent mechanism during reinfection, whereas infection at a later age protects against the development of these altered airway responses after reinfection.

21 November 2008 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
TSTae Won Song
Tae Won Song
KKKyung Won Kim
Kyung Won Kim
EKEun Soo Kim
Eun Soo Kim
JPJung‐Won Park
Jung‐Won Park
MSMyung Hyun Sohn Sohn
Myung Hyun Sohn Sohn
KKKyu‐Earn Kim
Kyu‐Earn Kim

14 December 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
HPHye Jung Park
Hye Jung Park
JPJung-Won Park
Jung-Won Park
MYMin-Suk Yang
Min-Suk Yang
MKMi-Yeong Kim
Mi-Yeong Kim
SKSae-Hoon Kim
Sae-Hoon Kim
HKHye-Ryun Kang
Hye-Ryun Kang

1 November 2000 in Allergy
Verified
Journal Article
Closed access
PDF file
JPJ. W. Park
J. W. Park
DKD. B. Kang
D. B. Kang
CKC. W. Kim
C. W. Kim
SKS. H. Ko
S. H. Ko
HYH. Y. Yum
H. Y. Yum
KLK. Y. Lee
K. Y. Lee